Phase I study of neoadjuvant S‐1 plus cisplatin with concurrent radiation for biliary tract cancer (Tokyo Study Group for Biliary Cancer: TOSBIC02)

Abstract Aim Neoadjuvant chemoradiotherapy may improve survival in patients with advanced cholangiocarcinoma. This Phase I study aimed to determine the recommended dose of neoadjuvant chemoradiotherapy and decide whether to move to a Phase II study. Methods Patients diagnosed with resectable stage I...

Full description

Bibliographic Details

Published in:	Annals of Gastroenterological Surgery
Main Authors:	Yuta Abe, Osamu Itano, Yusuke Takemura, Takuya Minagawa, Hidenori Ojima, Masahiro Shinoda, Minoru Kitago, Hideaki Obara, Naoyuki Shigematsu, Yuko Kitagawa
Format:	Article
Language:	English
Published:	Wiley 2023-09-01
Subjects:	biliary tract neoplasm chemoradiotherapy clinical trial Phase I neoadjuvant therapy postoperative complications
Online Access:	https://doi.org/10.1002/ags3.12682